Patient Capital Management is a Baltimore asset manager founded in 2020 by Samantha McLemore, CFA — Bill Miller's long-time co-manager (working together since 2002, running the flagship Opportunity Equity strategy since 2014). Continuing the Miller-school contrarian tradition, it practices "time arbitrage": exploiting behavioral mispricing to concentrate in controversial growth names (tech, healthcare, Bitcoin-related) at deep discounts to intrinsic value. Its site preserves Bill Miller's complete 1995-2022 market letters, alongside ongoing quarterly letters and webinars.
This is about Bill Miller's succession plan: Patient Capital has bought Opportunity Equity from Miller Value Partners, becoming an independent firm that manages about $1.5 billion, with the same team and strategy. There's no market outlook—it's a management and ownership update. Key names: Patient Capital, now run by Samantha McLemore, Miller's colleague for over 20 years; Bill Miller, who keeps a minority stake and stays invested in the products; and the investment vehicles—mutual funds, separate accounts, and private funds—continue unchanged. Note: this is a company press release, so it lacks financial details.
This is an acquisition event notice: Patient Capital Management has completed the acquisition of Miller Value Partners' Opportunity Equity business, operating independently with $1.5B in assets, with strategy and team continuity [Neutral].
Patient Capital Management announced the completion of its acquisition of the Opportunity Equity business from Miller Value Partners, transforming into an independent investment adviser managing $1.5B.
The article, published on May 30, 2023, announced that Patient Capital Management had completed the acquisition of the Opportunity Equity business from Miller Value Partners, a move the announcement said was part of a succession plan previously disclosed by legendary investor Bill Miller. Patient Capital was founded by Samantha McLemore in 2020 and had operated in coordination with Miller Value since its inception. Following the acquisition, the firm became a fully independent, SEC-registered investment adviser, managing $1.5B in assets for institutional and individual clients (as of April 30, 2023), with a team of 10 and headquarters in Baltimore, Maryland. Bill Miller retains a minority stake and continues to invest in the managed products.
Samantha McLemore leads the firm as founder, majority shareholder, CEO, and CIO; she has served as portfolio manager of the Opportunity Equity strategy for more than a decade and has worked with Bill Miller since entering the industry in 2002.
The article specifically notes that McLemore began her career at Legg Mason in 2002 and has since worked side by side with Bill Miller, her former co-manager and mentor. She founded Patient Capital in 2020 to bring the investment practice into the institutional market.
The firm promises that the name change will not affect investment operations: the same investment and administrative teams will continue to support the products, carrying forward an investment philosophy honed over decades and adhering to a patient, flexible, value-oriented approach.
The author quotes McLemore as saying: "While our name will change, you should expect continuity from us." In other words: "Although our name will change, you should expect continuity from us."
She then said: "We have the utmost confidence in the patient, flexible, value approach that's served clients well over the years." In other words: "We have the utmost confidence in this patient, flexible, value-oriented investment approach that has served clients well for many years."
On the product side, the strategy is available through three vehicles: a mutual fund with a track record of more than 20 years, separately managed accounts, and a private fund. The firm officially positions the strategy as an opportunistic, long-term, value-oriented equity strategy.
This marks the completion of Bill Miller's succession plan: the investment philosophy, team, and product structure have all been preserved, and the firm now operates independently with $1.5B in assets.
For investors, the points worth noting are: first, control over the strategy is clearly defined — McLemore is simultaneously founder, majority shareholder, CEO, and CIO, and the strategy is no longer attached to Miller Value; second, Bill Miller still retains a minority stake and invests in the related products, creating an alignment of interests; third, the product structure remains unchanged, covering three channels: mutual funds, separately managed accounts, and private funds. Institutional-view bias: this is an official press release from the acquirer, and the language carries a marketing and reassuring tone ("utmost confidence," "served clients well"), without disclosing performance, fee, or governance details; readers should treat it as an event announcement rather than an independent assessment.
| 标的 | 方向 | 作者态度一句话 | 关键数据 |
|---|---|---|---|
| Patient Capital Management | Not disclosed | Acquisition completed, independently operated, strategy continues, but the official tone carries marketing flair | Manages $1.5B, 10-person team, founded by McLemore in 2020 |
| Opportunity Equity business | Hold and observe | Continues to employ the existing strategy after acquisition, with unchanged product structure | Over 20 years of performance record, covering mutual funds/separately managed accounts/private funds |
| Miller Value Partners | Reduce position | Sells Opportunity Equity as planned, completing succession arrangement | Bill Miller retains a minority stake |
| Samantha McLemore | Not disclosed | Core helmsman, long-time collaborator with Bill Miller; the market should watch where management control lies | Entered the industry in 2002, founded Patient Capital in 2020, CEO and CIO |
| Bill Miller | Hold and observe | Retains a minority stake and invests in the product, creating aligned interests | Minority shareholder |
| Legg Mason | Not disclosed | Mentioned only as career background | Starting point of McLemore's career in 2002 |